EORTC AISBL / IVZW Avenue Mounierlaan, 83/11 Brussel 1200 Bruxelles • Belgie Belgique +32 2 774 16 11
Intranet • Home

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background

18001	TRIAL 18001-88001 Randomized phase III study of adjuvant immunization with NA17.A2 and melanoma differentiation peptides in HLA-A2 patients with primary ocular melanoma at high risk of relapse.
88941	Recombinant alpha-2b-Interferon with Dacarbazine, Vincristine, Bleomycin and Lomustine in metastatic malignant uveal melanoma: a pilot study

Back to Site-list